References
- Altman D G., Gore S M. Statistics in practice. The Devenshire Press, Torquay 1984
- Larsen S, Osnes M, Eidsaunet W, Sandvik L. Factors influencing the sample size, exemplified by studies in gastroduodcnal toler-ability of drugs. Scand J Gastroenterol 1985; 20: 395–400
- Larsen S, Sandvik L, Osnes M. The sample size in multicentre and stratified designed trials. Pharmaceut Med 1991; 5: 97–105
- Whitehead J. The design and analysis of sequential clinical trials. 2nd ed. Ellis Horwood, Chichester 1991
- Armitage P. Sequential medical trials. 2nd ed. Blackwell, Oxford 1975
- Pocock S J. Size of cancer clinical trials and stopping rules. Br J Cancer 1978; 38: 757–66
- O'Brien P C., Fleming T R. A multiple testing procedure for clinical trials. Biometrics 1979; 35: 549–56
- Lan K KG, Demets D L. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659–63
- Geller N L., Pocock S J. Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners. Biometrics 1987; 43: 213–23
- Lan K KG, Wittes J. The B-value: a tool for monitoring data. Biometrics 1988; 44: 579–85
- Trondsen E, Reiertsen O, Andersen O K., Rosseland A, Kjærsgaard P. Laparoscopic versus open cholecystectomy. Eur J Surg 1993; 159: 217–21
- Facey K. A sequential procedure for a phase II efficacy trial in hypercholesterolemia. Contr Clin Trials 1992; 13: 122–33
- Zucker K A. Surgical laparascopy. Quality Medical Publishing, Inc., St. Louis, MO 1991
- Huskisson E C. Measurements of pain. Lancet 1974; 2: 1127–31
- Larsen S, Aabakken L, Lillevold P E., Osnes M. Assessing soft data in clinical trials. Pharmaceut Med 1991; 5: 29–36
- Kendall M, Stuart A. The advanced theory of statistics. Charles Griffin & Co Ltd, London 1979; Vol II
- Chang M N. Confidence intervals for a normal mean following a group sequential test. Biometrics 1989; 45: 247–54
- Mardia K V., Kent J T., Bibby J M. Multivariate analysis. Academic Press Inc, London 1982
- Bross I. Sequential medical plans. Biometrics 1952; 8: 188–205
- Armitage P. Sequential tests in prophylactic and therapeutic trials. O J Med 1954; 23: 255–74
- Whitehead J. Overrunning and underrunning in sequential clinical trials. Contr Clin Trials 1992; 13: 106–21
- Rosner G L., Tsiatis A A. The impact that group sequential tests would have made on ECOG clinical trials. Stat Med 1989; 8: 505–16
- Propert K J., Kim K. Group sequential methods in multi-institutional cancer clinical trials. A case study. Pharmaceutical sequential statistical applications, K E. Peack. Marcel Dekker Inc, New York 1992